Optibrium applies deep learning to predict human panel-based sensory perception of novel compounds
Optibrium, a provider of software and artificial intelligence solutions for drug discovery, has announced the publication of a peer-reviewed study in the Journal of Computer-Aided Molecular Design, ‘Imputation of Sensory Properties Using Deep Learning’